Synoligo Biotechnologies
PrivateLast Round
Seed
Aug 1, 2022
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Synoligo Biotechnologies operates in Healthcare & Life Sciences and is based in Morrisville, North Carolina. Its latest recorded funding round was a Seed round in August 2022.
Synoligo Biotechnologies is a contract research and development organization (CRDO) that specializes in the manufacturing of complex and highly modified oligonucleotides for academic, biotech, and pharmaceutical sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synoligo Biotechnologies Comparables
Compare Synoligo Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ADViRNA | 83% | |
| Bio-Synthesis, Inc. | 80% | |
| Microsynth AG | 73% |
For institutional investors. Book with your work email.
Synoligo Biotechnologies Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 187% MoM, reaching 8.4K.
- Aug 19, 2026
Grew 19% QoQ, from 36 to 43 employees.
For institutional investors. Book with your work email.
Synoligo Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synoligo Biotechnologies's valuation, stock price, and market status.
Is Synoligo Biotechnologies a public or private company?
Synoligo Biotechnologies is a private company.
What is the current stock price of Synoligo Biotechnologies?
Synoligo Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Synoligo Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synoligo Biotechnologies worth (valuation)?
Valuation information for Synoligo Biotechnologies is not publicly available.
Can I buy Synoligo Biotechnologies stock?
Synoligo Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synoligo Biotechnologies's last funding round?
Synoligo Biotechnologies's most recent funding round was Seed on August 1, 2022.
Who are the main investors in Synoligo Biotechnologies?
Investor information for Synoligo Biotechnologies is not publicly disclosed.
Will Synoligo Biotechnologies IPO soon?
No public IPO plans have been announced for Synoligo Biotechnologies.
How can I track Synoligo Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Synoligo Biotechnologies's shares on secondary markets.